Jinan Babio Biotechnology Co., Ltd.

Jinan Babio Biotechnology Co., Ltd. Was established in 2003. It is a professional high-tech enterprise specializing in the research and development, production and sales of culture media and in vitro diagnostic reagents. The company successfully listed on the New Third Board in 2014 (stock name: Baibo Bio, stock code: 830774). The company has established a strict quality management system and has passed the international quality system certifications of ISO9001: 2008 and ISO13485: 2003. The company is equipped with internationally advanced automated production facilities and medical-grade standard purification workshops. At present, it has over 72 independent intellectual property rights, undertakes multiple national-level scientific research projects, and holds 91 medical device registration certificates approved by the State Food and Drug Administration. The company's products mainly involve dry powder culture media, disposable culture dishes, virus sampling, sterile swabs, rapid test kits, microbiological test reagents, POCT test reagents, biochemical diagnostic reagents, prenatal testing and other diagnostic equipment products. At present, the company's dry powder culture media, viral vectors, nasal/oral sampling swabs and rapid test kits have been sold to more than 56 countries. The product quality has been recognized by medical institutions and laboratories in various countries. The company has made contributions to the fight against the epidemic for people all over the world. In the future, Baibo Biotech will continue to strive and contribute to the global fight against the epidemic. Make new contributions!